We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-2 of 2

FDA enforcement of online advertising and promotional activities: emerging marketing opportunities come with legal and regulatory risk
  • Hogan Lovells
  • USA
  • April 13 2009

On April 2, 2009, the U.S. Food and Drug Administration (FDA) publicly released fourteen “untitled” letters to major pharmaceutical firms challenging the use of “sponsored links” and alleging that the links make product claims but fail to provide required risk information